A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Archives of General PsychiatryPublished 1 April 2002Open access
Katharine A. Phillips, Ralph S. Albertini, Steven A. Rasmussen
Citations318
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Fluoxetine is safe and more effective than placebo in delusional and nondelusional patients with BDD and the presence of major depression, obsessive-compulsive disorder, or a personality disorder.
Abstract
Fluoxetine is safe and more effective than placebo in delusional and nondelusional patients with BDD.
Keywords
PsychologySocial Sciences
Computers Environment and Urban SystemsStatistical power analysis for the behavioral sciences
65,645 Citations1990
Archives of General PsychiatryThe Yale-Brown Obsessive Compulsive Scale
7,464 Citations1989Wayne K. Goodman
In a study involving four raters and 40 patients with obsessive-compulsive disorder at various stages of treatment, interrater reliability for the total Yale-Brown Scale score and each of the 10 individual items was excellent, with high degree of internal consistency among all item scores demonstrated with Cronbach's alpha coefficient.
Archives of General PsychiatryThe Global Assessment Scale
4,952 Citations1976Jean Endicott
The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.
Archives of General PsychiatryThe Structured Clinical Interview for DSM-III-R (SCID)
4,364 Citations1992Robert L. Spitzer
The history, rationale, and development of the Structured Clinical Interview for DSM-III-R (SCID) is described, which is a semistructured interview for making the major Axis I DSM- III-R diagnoses.
Archives of General PsychiatryThe Yale-Brown Obsessive Compulsive Scale
2,749 Citations1989Wayne K. Goodman
Results from a previously reported placebo-controlled trial of fluvoxamine in 42 patients with obsessive-compulsive disorder showed that the Yale- Brown Scale was sensitive to drug-induced changes and that reductions in Yale-Brown Scale scores specifically reflected improvement in obsessive- compulsive disorder symptoms.
Archives of General PsychiatryThe Structured Clinical Interview for DSM-III-R (SCID)
1,627 Citations1992Janet B. W. Williams
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient site in Germany.
American Journal of PsychiatryThe Brown Assessment of Beliefs Scale: Reliability and Validity
709 Citations1998Jane L. Eisen, Katharine A. Phillips +4 more
The Brown Assessment of Beliefs Scale is a reliable and valid instrument for assessing delusionality in a number of psychiatric disorders and may help clarify whether delusional and nondelusional variants of disorders constitute the same disorder as well as whether delusionality affects treatment outcome and prognosis.
Journal of Personality DisordersThe Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). Part I: Description
706 Citations1995Michael B. First, Robert L. Spitzer +2 more
PubMedA severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.
675 Citations1997Katharine A. Phillips, Eric Hollander +4 more
The Yale Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder appears to be a reliable and valid measure of B DD severity and is a suitable outcome measure in treatment studies of BDD.
American Journal of PsychiatryBody dysmorphic disorder: 30 cases of imagined ugliness
584 Citations1993Katherine A. Phillips, Susan L. McElroy +3 more
This often secret, chronic disorder can cause considerable distress and impairment, may be related to obsessive-compulsive disorder or mood disorder, and may respond to serotonin reuptake-blocking antidepressants.
Biological PsychiatryThe relationship of obsessive–compulsive disorder to possible spectrum disorders: results from a family study
557 Citations2000O. Joseph Bienvenu, Jack Samuels +6 more
Findings indicate that certain somatoform and pathologic grooming conditions are part of the familial OCD spectrum, though other "spectrum" conditions may resemble OCD, and they do not appear to be important parts of the family spectrum.
Archives of General PsychiatryEfficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder
502 Citations1995John H. Greist
While the results of this meta-analysis support the superiority of clomipramine, head-to-head, double-blind comparisons of these compounds would be the best test of comparative efficacy and tolerability.
Oxford University Press eBooksThe broken mirror : understanding and treating body dysmorphic disorder
502 Citations2005Katharine A. Phillips
Journal of Studies on Alcohol SupplementEnsuring balanced distribution of prognostic factors in treatment outcome research.
459 Citations1994Robert L. Stout, Philip W. Wirtz +2 more
Urn randomization is randomization that is systematically based in favor of balancing that preserves randomization as the primary basis for assignment to treatment and is less susceptible to experimenter bias or manipulation of the allocation process by staff than is balancing.
American Journal of PsychiatryBody dysmorphic disorder: the distress of imagined ugliness
446 Citations1991Katharine A. Phillips
Whether body dysmorphic disorder is related to other psychiatric disorders, such as psychosis, mood disorder, social phobia, or obsessive-compulsive disorder, is unclear at this time.
Journal of Personality DisordersThe Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). Part II: Multi-Site Test-Retest Reliability Study
422 Citations1995Michael B. First, Robert L. Spitzer +8 more
Psychiatry ResearchThe modified Hamilton rating scale for depression: Reliability and validity
413 Citations1985Ivan W. Miller, S. Bishop +2 more
British Journal of DermatologySuicide in dermatological patients
380 Citations1997J.A. COTTERILL, W.J. Cunliffe
Patients with dermatological non‐disease, and particularly women with facial complaints, may be extremely depressed and at risk of suicide, and facial scarring may be an ‘at risk’ factor for suicide, emphasizing the positive early therapeutic role of isotretinoin.
Plastic & Reconstructive SurgeryBody Image Dissatisfaction and Body Dysmorphic Disorder in 100 Cosmetic Surgery Patients
349 Citations1998David B. Sarwer, Thomas A. Wadden +2 more
Cosmetic surgery patients did not demonstrate greater dissatisfaction with their overall appearance compared with the reported normal values of the measures, but when asked about the specific bodily feature they were considering for cosmetic surgery, they reported significantly greater dissatisfaction than a normative sample.
Social Psychiatry and Psychiatric EpidemiologyEpidemiology of somatoform disorders: a community survey in Florence
331 Citations1997Carlo Faravelli, S. Salvatori +4 more
The prevalence rates of somatoform disorders were generally found to be slightly lower than expected, and may be seen as one of the first in an area where knowledge is still scant.
Current clinical practiceObsessive Compulsive Disorder
306 Citations2022Robert Hudak, Jessica M. Gannon
Comprehensive PsychiatryThe high prevalence of “Soft” bipolar (II) features in atypical depression
302 Citations1998Giulio Perugi, Hagop S. Akiskal +6 more
The data suggest that the "atypicality" of depression is favored by affective temperamental dysregulation and anxiety comorbidity, clinically manifesting in a mood disorder subtype that is preponderantly in the realm of bipolar II.
Archives of General PsychiatryClomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder
277 Citations1999Eric Hollander, Andrea Allen +5 more
Journal of the American Academy of DermatologyRate of body dysmorphic disorder in dermatology patients
273 Citations2000Katharine A. Phillips, Raymond G. Dufresne +2 more
BDD appears relatively common among patients seeking dermatologic treatment, and dermatologists should assist dermatologists in identifying these potentially high-risk patients.
PubMedA comparison of delusional and nondelusional body dysmorphic disorder in 100 cases.
246 Citations1994Katherine A. Phillips, Susan L. McElroy +3 more
Findings have implications for BDD's treatment and classification, suggesting that inclusion of a delusional (psychotic) subtype of BDD should be considered for future editions of DSM.
Psychiatry and Clinical NeurosciencesDemographic features of patients seeking cosmetic surgery
214 Citations1998Jun Ishigooka, Mitsuhiro Iwao +4 more
Male subjects were characterized to have a greater number of mental disorders, especially dysmorphophobia, and showed the narrow age range between teenage and young adult age when they were preoccupied with their ‘deformity’, and poor social function.
British Journal of DermatologyDermatological non-disease: a common and potentially fatal disturbance of cutaneous body image
200 Citations1981J.A. COTTERILL
A group of patients presenting with dermatological complaints but with no significant objective dermatological pathology on examination are described, with complaints related to the face were burning, intense itching and hirsutes.
Journal of the American Academy of Child & Adolescent PsychiatryThirty‐Three Cases of Body Dysmorphic Disorder in Children and Adolescents
192 Citations1999Ralph S. Albertini, Katharine A. Phillips
Preliminary data suggest that serotonin reuptake inhibitors may be an effective treatment in this age group of children and adolescents with body dysmorphic disorder (BDD), a preoccupation with a nonexistent or slight defect in appearance.
The Journal of Clinical PsychiatryEfficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder
180 Citations1998Katharine A. Phillips, Megan M. Dwight +1 more
It is suggested that fluvoxamine is a safe and effective treatment for BDD, including its delusional disorder variant, and controlled treatment trials are needed to confirm these findings.
The Journal of Nervous and Mental DiseaseQuality of Life for Patients with Body Dysmorphic Disorder
173 Citations2000Katharine A. Phillips
It is indicated that patients with BDD have notably poor mental health status and mental health-related quality of life.
The Journal of Clinical PsychiatryDelusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder
162 Citations2001Katharine A. Phillips, Susan L. McElroy +3 more
Degree of delusionality did not predict fluvoxamine response, and delusionality significantly improved, in this prospective, open-label study of delusional variant of body dysmorphic disorder.
American Journal of PsychiatryTreatment of body-dysmorphic disorder with serotonin reuptake blockers
155 Citations1989Eric Hollander, Michael R. Liebowitz +3 more
The authors describe five patients with body-dysmorphic disorder who responded preferentially to serotonin reuptake blockers, and discuss similarities and differences between this disorder and obsessive-compulsive disorder.
American Journal of PsychiatryBody dysmorphic disorder in the DSM-IV field trial for obsessive- compulsive disorder
138 Citations1995Daphne Simeon, Eric Hollander +3 more
The findings suggest that the two disorders are strongly related but also have differences that require further investigation.
Journal of Child and Family StudiesAssessing the Prevalence of Body Dysmorphic Disorder in an Ethnically Diverse Group of Adolescents
133 Citations1999Stephen B. Mayville, Roger C. Katz +2 more
Results showed that adolescent girls were more dissatisfied with their bodies than adolescent boys, and that African-Americans of both genders were less dissatisfied withTheir bodies than Caucasians, Asians, and Hispanics.
The Canadian Journal of PsychiatryMonosymptomatic Hypochondriacal Psychosis: A Diagnostic Checklist Based on 50 Cases of the Disorder
112 Citations1982Alistair Munro, Joanne Chmara
A checklist of symptoms and characteristics of monosymptomatic hypochondriacal psychosis is presented, based on a unique series of 50 cases of the disorder, which appears to be a subtype of paranoia.
International Clinical PsychopharmacologyFluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia)
109 Citations1996Giulio Perugi, Daniele Giannotti +4 more
Flint fluvoxamine may be effective in the treatment of BDD, and several outcome measures showed a significant improvement from baseline to week 10.
Annals of Plastic SurgeryBody Image Concerns of Reconstructive Surgery Patients: An Underrecognized Problem
89 Citations1998David B. Sarwer, Linton A. Whitáker +2 more
Results underscore the importance of screening for body image dissatisfaction in persons with an objective deformity and plastic surgeons are in an optimal position to identify body image concerns in these patients and provide appropriate referrals for psychotherapy.
American Journal of PsychiatryPlacebo response in panic disorder
68 Citations1988William Coryell, R Noyes
Patients with panic disorder or agoraphobia with panic attacks who took placebo for 8 weeks in two double-blind studies were significantly more likely to show a placebo response as were those with lower anxiety ratings at the outset of treatment.
International Journal of Psychiatry in Clinical PracticePrevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population
66 Citations1997Giulio Perugi, Daniele Giannotti +6 more
Body dysmorphic disorder has a generally chronic course, causes considerable distress and a serious impairment in many areas, and shows strong links with mood and obsessive-compulsive disorders.
PubMedPredictors of placebo response: a retrospective analysis.
61 Citations1992Charles S. Wilcox, Jay B. Cohn +5 more
This retrospective evaluation involved 197 patients from independent clinical investigations of four antidepressant medications and gender, marital status, age; age; education; duration of illness; and severity of depressive symptomatology, as measured by Hamilton Rating Scale for Depression (HAM-D or HDRS) scores.
Journal of the American Academy of Child & Adolescent PsychiatryCase Study: Body Dysmorphic Disorder in Adolescents
52 Citations1995Katharine A. Phillips, Katherine D. Atala +1 more
Four cases of adolescents with body dysmorphic disorder are presented, all of who responded to a serotonin reuptake inhibitor and available data on the treatment of this distressing and often-disabling disorder is reviewed.
The Journal of Nervous and Mental DiseasePerceived Stress in Body Dysmorphic Disorder
42 Citations1998Lynne M. DeMarco, Lisa C. Li +2 more
Journal of the American Academy of Child & Adolescent PsychiatryCASE STUDY Clomipramine Treatment of Delusional Disorder-Somatic Type
42 Citations1988Adrian Sondheimer
International Clinical PsychopharmacologyClomipramine treatment of delusional disorder, somatic type
14 Citations1999T. Wada, S. Kawakatsu +3 more
The British Journal of PsychiatryBody dysmorphic disorder
5 Citations1997C. Feinmann, Susan Cunningham
The data on Axis I comorbidity are consistent with the argu ments for a general vulnerability factor in the aetiology of panic disorder, and patients themselves discriminate between primary disorder and secondary or derivative disorders, which may complicate the long-term course of the primary illness.
Adolescent PsychiatryBody Dysmorphic Disorder in Adolescents
4 Citations2018Himanshu Sharma, Bharti Sharma +1 more
This review aims to comprehensively cover the present understanding of BDD, including clinical features, epidemiology, psychopathology, nomenclature, comorbidity and management, and to develop better treatment approaches.